← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue decreased 60.7% to $95.7M, while Net income decreased 418.6% to ($49.4M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $95.7MWatch
- Profitability — Net income ($49.4M)Watch
- Cash generation — Free cash flow ($46.0M)Note
- Accounting — Formula-grey distress score · no manipulation flag · earnings quality safeNote
- Insiders — 1 buys; 0 sells in 365 daysOK
- Capital — dividends paid were $10.5MNote
Business
FutureFuel Corp.: Chemicals Segment Our Chemicals segment is a premier provider of custom manufacturing solutions, serving a diverse portfolio of third-party customers.
Where the revenue comes from
Fiscal 2025, as FutureFuel Corp. reports it. History and quarterly detail are in the app.
- Chemicals$59.6M
- Biofuels$36.2M
Leadership changes
From FutureFuel Corp.'s own filings, the day they're filed.
- G. Bruce Greer · Director · appointmenteff. 2025-12-08
- Charles W. Lyon · Chief Commercial Officer · departureeff. 2025-03-31
- Tom McKinlay · Chief Executive Officer · departureeff. 2024-09-30
Latest filings
- 8-K · Company announcement2026-08-31
- DEF 14A · Annual proxy (pay & governance)2026-08-12
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-08-10
- 8-K · Company announcement2026-07-28
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about FutureFuel Corp., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.